COLL
COLL
NASDAQ · Pharmaceuticals

Collegium Pharmaceutical Inc

$23.39
+0.35 (+1.52%)
As of Sep 22, 1:50 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +105.9% upside
Low Target $33.48
Average Target $48.15
High Target $61.72
Current Price $23.39
Current
$23.39
Target
$48.15
$33.48 $48.15 avg $61.72
Scenario Analysis
Bear Case
$33.48
43.1%
Low target
Base Case
$48.15
+105.9%
Avg target
Bull Case
$61.72
+163.9%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$50.79
-53.9% from high
52-Week Low
$21.65
+8.0% from low
Target vs 52W High
$48.15
-5.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%